Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester

Gynecologic and Obstetric Investigation

Volumn 70, Issue 1, 2010, Pages 60-63

  Valinen, Yrtti ^a   Peuhkurinen, Sini ^a   Järvelä, Ilkka Y ^a   Laitinen, Päivi ^a   Ryynanen, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

ADAM12; Down's syndrome, screening; Free human chorionic gonadotropin; Pregnancy associated plasma protein A

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE PROTEIN 12; ADAM PROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCULATION; CORRELATION ANALYSIS; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SAMPLING; SCREENING; SECRETION; SMOKING; WEIGHT;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MEMBRANE PROTEINS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RISK FACTORS; SMOKING;

EID: 77449111384     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000289178     Document Type: Article

References (14)

1. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM: A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998;273:157-166.
2. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ: ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor- binding protein-3. J Biol Chem 2000;275: 18574-18580.
3. Laigaard J, Sorensen T, Frohlich C, et al: ADAM 12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 2003;23:1086-1091.
4. Laigaard J, Spencer K, Christiansen M, et al: ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 2006;26:973-979.
5. Cowans NJ, Spencer K: First-trimester ADAM12 and PAPP-A as markers for intra- uterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27:264-271.
6. Jauniaux E, Johns J, Burton GJ: The role of ultrasound imaging in diagnosing and investigating early pregnancy failure. Ultrasound Obstet Gynecol 2005;25:613-624.
7. Jauniaux E, Poston L, Burton GJ: Placental- related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006; 12:747-755.
8. Hay DL: Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-1275.
9. Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM: Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem 1998;273:16993-16997.
10. Spencer K, Vereecken A, Cowans NJ: Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation. Prenat Diagn 2008;28:209-211.
11. Laigaard J, Gros Pedersen N, Olesen Larsen S, et al: ADAM12 in first trimester maternal serum from pregnancies conceived by assisted reproduction techniques (ART). Prenat Diagn 2009;29:628-629.
12. Niemimaa M, Heinonen S, Seppala M, Ryynanen M: The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency. BJOG 2003; 110: 664-667.
13. Jauniaux E, Burton GJ: The effect of smoking in pregnancy on early placental morphology. Obstet Gynecol 1992;79:645-648.
14. Bernstein IM, Mongeon JA, Badger GJ, Solomon L, Heil SH, Higgins ST: Maternal smoking and its association with birth weight. Obstet Gynecol 2005;106:986-991.